Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.
about
Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili.Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trialImproved detection of Streptococcus pneumoniae in middle-ear fluid cultures by use of a gentamicin-containing medium.Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young childrenMechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.Evaluation of polymerase chain reaction (PCR) for diagnosing Haemophilus influenzae b meningitis.Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment targetTreatment of acute otitis media consensus recommendations.Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.Are cephalosporins appropriate for the treatment of acute otitis media in this era of increasing antimicrobial resistance among common respiratory tract pathogens?Treatment of otitis media by transtympanic delivery of antibiotics.Predictive value of double tympanocentesis in acute otitis media.Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.Consistency of diagnostic criteria for acute otitis media: a review of the recent literature.Antibiotics versus placebo or watchful waiting for acute otitis media: a meta-analysis of randomized controlled trials.Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatmeAcute otitis media in infants: the disease and the illness. Clinical distinctions for the new treatment paradigm.Efficacy of linezolid in experimental otitis mediaExperimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placeboSystemic inflammatory responses in children with acute otitis media due to Streptococcus pneumoniae and the impact of treatment with clarithromycin.Clinical/otologic score before and during treatment of acute otitis media.A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age.Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin.Correlations between Microbiological Outcomes and Clinical Responses in Patients with Severe Pneumonia.Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media.Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication.Study design questions in treatment of children with acute otitis media.High-dose versus standard-dose amoxicillin for acute otitis media.Outcome of Acute Otitis Media and its Relation to Clinical Features and Nasopharyngeal Colonization at the Time of Diagnosis
P2860
Q24793297-C9D86C00-C099-4411-ADD7-7DE1645CDCC0Q33706016-3557EAD8-B216-4909-947B-3817B42B476DQ33848675-4D876C0E-26B7-4C3C-951F-F12A922B8431Q33963176-A6CF496C-A031-4E6A-AAE9-DBEA383790EDQ33978422-5DBDD105-193B-4D4D-BB19-EBBC5690975EQ34498620-35BB8626-2371-4142-A3FC-421D51FEAE42Q34530500-6B20FF91-3CA5-4F2C-B304-CB96B1DA7D25Q34580853-164F520E-D18F-4AAC-8DED-FDD749130370Q34776345-9FAC4B81-F09D-41FF-B080-ABF6FC4B8700Q35692693-A85C1469-9A1D-409F-B6CB-50D93024B595Q36056738-06A40C3B-D5F0-4D2C-BB1B-7EE0B91FCFBFQ36133289-27B47C1E-6D65-467D-923E-8749B6D7A109Q36320589-2D3B32EF-50FD-4A6C-877A-B6082E05EA25Q36320595-120C44AA-5206-4E6B-97C4-EE94CD423108Q36350568-580FAD24-A6A8-4FAE-A7F9-3833D858099BQ36746116-5426104E-B064-4C6D-8D0E-25B09017A434Q37489215-09D84C57-5F82-416F-A7FD-465B5056DC8CQ37489324-42622E99-756B-4685-BA21-65CEC509227BQ38032134-C90667C4-B9D5-4B2F-AF09-651288B541F7Q39473141-A0B880B4-3E4E-4BE2-846F-4E30B9748211Q39652247-086E6B32-A6F2-42F8-8C61-4F6F973D8E84Q39785699-2B6A4D3C-D4FC-4FBD-844B-F41F425835A3Q40436306-AEA8003E-D91A-48A7-84CA-BC425F353E13Q40515893-D3B75192-4581-4702-BB4A-F76FE1B2A409Q41912201-B9988E44-7E2B-4864-A14C-5FFEA5594B64Q42097160-C3814090-76B1-4218-A372-2F565CB65DBCQ42730027-2D52BBE2-2BF4-4A28-A8D7-BE35AE2A4DA4Q43102010-67B5180D-ACCF-4151-A004-28F32225C389Q43188427-2FEF1C73-E353-4B7E-841C-4458FCACFABCQ44741626-A2B6C02A-3821-4E11-BC16-29B9EC671D3CQ58145211-834D8EEE-6CD4-48DD-B868-4DD9C789794F
P2860
Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Early eradication of pathogens ...... ith improved clinical outcome.
@en
Early eradication of pathogens ...... ith improved clinical outcome.
@nl
type
label
Early eradication of pathogens ...... ith improved clinical outcome.
@en
Early eradication of pathogens ...... ith improved clinical outcome.
@nl
prefLabel
Early eradication of pathogens ...... ith improved clinical outcome.
@en
Early eradication of pathogens ...... ith improved clinical outcome.
@nl
P2093
P1476
Early eradication of pathogens ...... ith improved clinical outcome.
@en
P2093
P304
P356
10.1097/00006454-199809000-00005
P577
1998-09-01T00:00:00Z